Recordati Industria Chimica E Farmaceutica (RCDTF) News Today $65.44 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestBuy This Stock RCDTF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Shares Up 33.6% - Should You Buy?June 13, 2025 | marketbeat.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 52-Week High - What's Next?June 13, 2025 | marketbeat.comRecordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Up 66.9% in MayJune 1, 2025 | marketbeat.comDrug maker Recordati's Q1 revenue rises 11.9%, confirms 2025 guidanceMay 9, 2025 | msn.comRecordati stock rises following 1Q earnings beatMay 8, 2025 | investing.comRecordati, la cassa balza a 158 milioni e il debito cala a 2 miliardiMay 8, 2025 | msn.comShort Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Increases By 22.9%May 5, 2025 | marketbeat.comRecordati Industria Chimica e Farmaceutica SPA (0KBS) Receives a Hold from RBC CapitalApril 26, 2025 | markets.businessinsider.comRecordati, la Fda amplia l’uso del farmaco Isturisa. Ma il titolo cade in borsa, ecco perchéApril 18, 2025 | msn.com3 European Stocks Estimated To Be Trading At Discounts Of Up To 40.1%April 17, 2025 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Hits New 52-Week Low - Here's WhyApril 9, 2025 | marketbeat.comRecordati Industria Chimica e Farmaceutica S.p.A.April 7, 2025 | uk.investing.comRecordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Down 47.9% in MarchMarch 29, 2025 | marketbeat.comRecordati upgraded to Hold from Sell at Deutsche BankMarch 19, 2025 | markets.businessinsider.comRecordati Reports Strong 2024 Financial Results and Reaffirms ESG CommitmentMarch 18, 2025 | msn.comRecordati price target raised to EUR 55 from EUR 53 at RBC CapitalMarch 16, 2025 | markets.businessinsider.comRecordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Up 121.2% in FebruaryMarch 15, 2025 | marketbeat.com3 European Stocks Estimated To Be Undervalued In March 2025March 3, 2025 | finance.yahoo.comRecordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest UpdateMarch 2, 2025 | marketbeat.comRecordati Industria Chimica e Farmaceutica SPA (0KBS) Receives a Hold from Kepler CapitalFebruary 21, 2025 | markets.businessinsider.comRecordati stock falls on stake sale newsFebruary 19, 2025 | in.investing.comRecordati stock rating cut to sell by Deutsche BankFebruary 7, 2025 | msn.comRecordati downgraded to Sell from Hold at Deutsche BankFebruary 7, 2025 | markets.businessinsider.comRecordati Industria Chimica e Farmaceutica S.p.A. (0KBS.IL)February 4, 2025 | ca.finance.yahoo.comShort Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Grows By 26.7%January 18, 2025 | marketbeat.comRecordati and its top investor say no plans for deal with AngeliniJanuary 17, 2025 | msn.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Hits New 1-Year High - Here's What HappenedDecember 17, 2024 | marketbeat.comRBC Capital Keeps Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)December 15, 2024 | markets.businessinsider.comAngelini-Recordati, il mercato non crede al maxi-polo della farmaceuticaNovember 28, 2024 | msn.comAngelini Pharma Said to Discuss Combination With CVC’s RecordatiNovember 26, 2024 | bloomberg.comRecordati’s Strategic Share Buyback InitiativeNovember 21, 2024 | markets.businessinsider.comRecordati Completes Share Buy-Back ProgramNovember 11, 2024 | markets.businessinsider.comRecordati Launches Share Buy-Back Program to Boost IncentivesNovember 11, 2024 | markets.businessinsider.comItaly's Recordati sees no impact from potential US pharma tariffsNovember 9, 2024 | msn.comRecordati Enhances Share Value with Buyback ProgramNovember 7, 2024 | markets.businessinsider.comRBC Capital Reaffirms Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)November 6, 2024 | markets.businessinsider.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Sets New 52-Week High - Still a Buy?November 1, 2024 | marketbeat.comRecordati Advances in Share Buyback ProgramOctober 30, 2024 | markets.businessinsider.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Hits New 12-Month Low - Time to Sell?October 25, 2024 | marketbeat.comKepler Capital Remains a Hold on Recordati Industria Chimica e Farmaceutica SPA (0KBS)October 24, 2024 | markets.businessinsider.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 1-Year High - Here's What HappenedOctober 21, 2024 | marketbeat.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 12-Month High - Here's What HappenedOctober 15, 2024 | marketbeat.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 12-Month Low - Should You Sell?October 14, 2024 | marketbeat.comKepler Capital Reaffirms Their Hold Rating on Recordati Industria Chimica e Farmaceutica SPA (0KBS)October 6, 2024 | markets.businessinsider.comRecordati shares jump on deal with Sanofi for Enjaymo rightsOctober 4, 2024 | investing.comRecordati to acquire worldwide rights to Sanofi’s antibody EnjaymoOctober 4, 2024 | msn.comRECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISEOctober 4, 2024 | markets.businessinsider.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 12-Month Low at $52.25September 27, 2024 | marketbeat.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 1-Year Low at $52.25August 27, 2024 | marketbeat.comRecordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 1-Year High at $52.25August 26, 2024 | marketbeat.com Get Recordati Industria Chimica E Farmaceutica News Delivered to You Automatically Sign up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter. Email Address RCDTF Media Mentions By Week RCDTF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCDTF News Sentiment▼0.000.58▲Average Medical News Sentiment RCDTF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCDTF Articles This Week▼01▲RCDTF Articles Average Week Get Recordati Industria Chimica E Farmaceutica News Delivered to You Automatically Sign up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Astellas Pharma News MEI Pharma News Oncology Pharma News Silence Therapeutics News UCB News Chugai Pharmaceutical News Zoetis News Takeda Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RCDTF) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica E Farmaceutica S.P.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recordati Industria Chimica E Farmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
